• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to 3-BroMo-7-azaindole-5-carbaldehyde (CAS No. 1190317-92-0)

3-BroMo-7-azaindole-5-carbaldehyde, identified by its Chemical Abstracts Service (CAS) number 1190317-92-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This heterocyclic aldehyde derivative combines the structural features of azaindole with a brominated aromatic ring, making it a versatile intermediate in the synthesis of biologically active molecules. The presence of both a carbonyl group and a bromine substituent enhances its reactivity, facilitating diverse chemical transformations that are crucial for drug discovery and development.

The compound belongs to the broader class of azaindoles, which are nitrogen-containing analogs of indole and have been extensively studied for their potential pharmacological properties. Azaindoles exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer effects, making them valuable scaffolds for medicinal chemistry. The introduction of a bromine atom at the 3-position and a formyl group at the 5-position in 3-BroMo-7-azaindole-5-carbaldehyde further modulates its pharmacokinetic and pharmacodynamic profiles, enhancing its suitability for further derivatization and therapeutic applications.

In recent years, 3-BroMo-7-azaindole-5-carbaldehyde has been explored as a key intermediate in the synthesis of novel therapeutic agents. Its unique structural framework allows for selective functionalization at multiple sites, enabling the development of compounds with tailored biological activities. For instance, the bromine atom can be readily engaged in cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings, while the aldehyde group can undergo condensation reactions to form Schiff bases or participate in Michael additions. These reactions are fundamental in constructing complex molecular architectures that mimic natural products or target specific biological pathways.

One of the most compelling aspects of 3-BroMo-7-azaindole-5-carbaldehyde is its utility in generating derivatives with enhanced binding affinity to biological targets. Researchers have leveraged this compound to develop inhibitors of kinases and other enzymes implicated in cancer progression. The azaindole core disrupts key protein-protein interactions by occupying hydrophobic pockets or binding to metal ions, while the bromine substituent provides a handle for further chemical modifications to optimize drug-like properties such as solubility, bioavailability, and metabolic stability. Such modifications are critical for advancing lead compounds through preclinical testing and into clinical trials.

The pharmaceutical industry has shown particular interest in 3-BroMo-7-azaindole-5-carbaldehyde due to its potential as a building block for next-generation therapeutics. Its incorporation into drug candidates has led to promising results in preclinical studies, where derivatives have demonstrated efficacy against various diseases without significant off-target effects. The compound’s ability to undergo regioselective functionalization makes it an attractive choice for medicinal chemists seeking to design molecules with precise biological activity. Furthermore, its synthetic accessibility allows for rapid screening of large libraries of analogs, accelerating the discovery process.

Recent advancements in computational chemistry have further highlighted the significance of 3-BroMo-7-azaindole-5-carbaldehyde as a pharmacophore. Molecular modeling studies indicate that this compound can effectively interact with biological targets by adopting specific conformations that maximize binding affinity. The combination of quantum mechanical calculations and machine learning algorithms has enabled researchers to predict optimal substitution patterns on the azaindole scaffold, including the placement of halogen atoms and other functional groups. These predictions guide synthetic efforts toward high-affinity binders, reducing the time and cost associated with hit identification and optimization.

The versatility of 3-BroMo-7-azaindole-5-carbaldehyde extends beyond its role as an intermediate in drug synthesis; it also serves as a valuable tool for studying enzyme mechanisms and developing probes for biochemical pathways. For example, fluorophore-tagged derivatives can be used to monitor protein-protein interactions or track metabolic processes in living cells. Such applications underscore the compound’s importance not only in medicinal chemistry but also in broader biochemical research.

In conclusion,3-BroMo-7-azaindole-5-carbaldehyde (CAS No. 1190317-92-0) represents a significant advancement in synthetic organic chemistry and pharmaceutical development. Its unique structural features enable diverse chemical transformations that are essential for creating novel therapeutic agents with improved efficacy and safety profiles. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone in the design and synthesis of biologically active molecules that address unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)